Immunotherapy Drugs Market Size, Share & Industry Analysis, By Type (Immune Checkpoint Inhibitor, Monoclonal Antibodies (mAbs), CAR-T Cell Therapies, Cancer Vaccines, and Others), By Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), By Route of Administration (Intravenous and Subcutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: | Report ID: FBI114938

To get information on various segments, share your queries with us

Global Immunotherapy Drugs Market Scope
Study Period	2021-2034
Base Year	2025
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 15.16% from 2026-2034
Unit	Value (USD Billion)
By Type	Monoclonal Antibodies (mAbs) CAR-T Cell Therapies Cancer Vaccines Others
By Indication	Oncology Autoimmune Diseases Infectious Diseases Others
By Route of Administration	Intravenous Subcutaneous
By Distribution Channel	Hospital Pharmacies Retail Pharmacies & Drug Stores Online Pharmacies
By Region	North America (By Type, Indication, Route of Administration, Distribution Channel, and Country) U.S. Canada Europe (By Type, Indication, Route of Administration, Distribution Channel, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Type, Indication, Route of Administration, Distribution Channel, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Type, Indication, Route of Administration, Distribution Channel, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Type, Indication, Route of Administration, Distribution Channel, and Country/Sub-region) GCC South Africa Rest of the Middle East & Africa